Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03141671 |
| Title | Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) |
| Recruitment | Active, not recruiting |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Dana-Farber Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, San Diego | San Diego | California | 92093 | United States | Details | |
| University of California, San Francisco | San Francisco | California | 94158 | United States | Details | |
| Yale Cancer Center | New Haven | Connecticut | 06510 | United States | Details | |
| University of Chicago | Chicago | Illinois | 60637 | United States | Details | |
| Dana-Farber Cancer Institute/Brigham and Women's Hospital | Boston | Massachusetts | 02215 | United States | Details | |
| University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |